As expected, a stepwise increase in liver fat content and risk of NAFLD was seen across genotypes for both PNPLA3, TM6SF2, and combined allele counts (Figure 3). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.